Literature DB >> 9847282

Role of inducible nitric oxide synthase in endotoxin-induced acute lung injury.

A S Kristof1, P Goldberg, V Laubach, S N Hussain.   

Abstract

The role of nitric oxide (NO) in lung injury remains unclear. Both beneficial and detrimental roles have been proposed. In this study, we used mutant mice lacking the inducible nitric oxide synthase (iNOS) to assess the role of this isoform in sepsis-associated lung injury. Wild-type and iNOS knockout mice were injected with either saline or Escherichia coli endotoxin (LPS) 25 mg/kg and killed 6, 12, and 24 h later. Lung injury was evaluated by measuring lactate dehydrogenase activity in the bronchoalveolar lavage, pulmonary wet/dry ratio, and immunostaining for nitrotyrosine formation. In the wild-type mice, LPS injection elicited more than a 3-fold rise in lactate dehydrogenase activity, a significant rise in lung wet/dry ratio and extensive nitrotyrosine staining in large airway and alveolar epithelium, macrophages, and pulmonary vascular cells. This was accompanied by induction of iNOS protein and increased lung nitric oxide synthase activity. By comparison, LPS injection in iNOS knockout mice elicited no iNOS induction and no significant changes in lung NOS activity, lactate dehydrogenase activity, lung wet/dry ratio, or pulmonary nitrotyrosine staining. These results indicate that mice deficient in iNOS gene are more resistant to LPS-induced acute lung injury than are wild-type mice.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9847282     DOI: 10.1164/ajrccm.158.6.9802100

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  67 in total

1.  The effects of aging on pulmonary oxidative damage, protein nitration, and extracellular superoxide dismutase down-regulation during systemic inflammation.

Authors:  Marlene E Starr; Junji Ueda; Shoji Yamamoto; B Mark Evers; Hiroshi Saito
Journal:  Free Radic Biol Med       Date:  2010-11-17       Impact factor: 7.376

Review 2.  Regulators of endothelial and epithelial barrier integrity and function in acute lung injury.

Authors:  Rudolf Lucas; Alexander D Verin; Stephen M Black; John D Catravas
Journal:  Biochem Pharmacol       Date:  2009-02-03       Impact factor: 5.858

Review 3.  Transepithelial migration of neutrophils: mechanisms and implications for acute lung injury.

Authors:  Rachel L Zemans; Sean P Colgan; Gregory P Downey
Journal:  Am J Respir Cell Mol Biol       Date:  2008-10-31       Impact factor: 6.914

Review 4.  Contribution of neutrophils to acute lung injury.

Authors:  Jochen Grommes; Oliver Soehnlein
Journal:  Mol Med       Date:  2010-10-18       Impact factor: 6.354

5.  Airway reactivity, inflammatory cell influx and nitric oxide in guinea-pig airways after lipopolysaccharide inhalation.

Authors:  T J Toward; K J Broadley
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

6.  Artesunate Protects LPS-Induced Acute Lung Injury by Inhibiting TLR4 Expression and Inducing Nrf2 Activation.

Authors:  Deli Zhao; Jinling Zhang; Guangquan Xu; Qiushi Wang
Journal:  Inflammation       Date:  2017-06       Impact factor: 4.092

7.  Nobiletin-Ameliorated Lipopolysaccharide-Induced Inflammation in Acute Lung Injury by Suppression of NF-κB Pathway In Vivo and Vitro.

Authors:  Weifeng Li; Ruoqi Zhao; Xiumei Wang; Fang Liu; Jinmeng Zhao; Qing Yao; Wenbing Zhi; Zehong He; Xiaofeng Niu
Journal:  Inflammation       Date:  2018-06       Impact factor: 4.092

Review 8.  Pathogenesis of malaria and clinically similar conditions.

Authors:  Ian A Clark; Lisa M Alleva; Alison C Mills; William B Cowden
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

9.  Resolution of experimental lung injury by monocyte-derived inducible nitric oxide synthase.

Authors:  Franco R D'Alessio; Kenji Tsushima; Neil R Aggarwal; Jason R Mock; Yoshiki Eto; Brian T Garibaldi; Daniel C Files; Claudia R Avalos; Jackie V Rodriguez; Adam T Waickman; Sekhar P Reddy; David B Pearse; Venkataramana K Sidhaye; Paul M Hassoun; Michael T Crow; Landon S King
Journal:  J Immunol       Date:  2012-07-27       Impact factor: 5.422

10.  Accelerated dosing frequency of a pulmonary formulation of tissue plasminogen activator is well-tolerated in mice.

Authors:  Kathleen A Stringer; Meghan Tobias; John S Dunn; Jackie Campos; Zachary Van Rheen; Mitra Mosharraf; Rajiv Nayar
Journal:  Clin Exp Pharmacol Physiol       Date:  2008-07-29       Impact factor: 2.557

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.